BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G84-98. [PMID: 31657225 DOI: 10.1152/ajpgi.00118.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Santos AA, Afonso MB, Ramiro RS, Pires D, Pimentel M, Castro RE, Rodrigues CMP. Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice. Gut Microbes 2020;12:1-18. [PMID: 33300439 DOI: 10.1080/19490976.2020.1840766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Albhaisi S, Sanyal AJ. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:665987. [PMID: 34040583 DOI: 10.3389/fendo.2021.665987] [Reference Citation Analysis]
3 Li Y, Yi J, Zeng Q, Liu Y, Yang B, Liu B, Li Y, Mehmood K, Hussain R, Tang Z, Zhang H, Li Y. Zearalenone exposure mediated hepatotoxicity via mitochondrial apoptotic and autophagy pathways: Associated with gut microbiome and metabolites. Toxicology 2021;462:152957. [PMID: 34537261 DOI: 10.1016/j.tox.2021.152957] [Reference Citation Analysis]
4 Tang D, Zhang Q, Duan H, Ye X, Liu J, Peng W, Wu C, Angeloni C. Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/9218738] [Reference Citation Analysis]
5 Philips CA, Schnabl B, Bajaj JS. Gut microbiome and alcohol-associated liver disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2021.12.016] [Reference Citation Analysis]
6 Clarembeau F, Bale G, Lanthier N. Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clin Sci (Lond) 2020;134:2117-35. [PMID: 32820802 DOI: 10.1042/CS20200022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Aygün C, Tözün N. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot. J Gastrointest Cancer 2021. [PMID: 34750696 DOI: 10.1007/s12029-021-00736-5] [Reference Citation Analysis]
8 Meng Z, Huang S, Sun W, Yan S, Chen X, Diao J, Zhou Z, Zhu W. A Typical Fungicide and Its Main Metabolite Promote Liver Damage in Mice through Impacting Gut Microbiota and Intestinal Barrier Function. J Agric Food Chem 2021;69:13436-47. [PMID: 34735141 DOI: 10.1021/acs.jafc.1c05508] [Reference Citation Analysis]
9 Ramai D, Facciorusso A, Vigandt E, Schaf B, Saadedeen W, Chauhan A, di Nunzio S, Shah A, Giacomelli L, Sacco R. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Cells 2021;10:3401. [PMID: 34943908 DOI: 10.3390/cells10123401] [Reference Citation Analysis]
10 Chen T, Ding R, Chen X, Lu Y, Shi J, Lü Y, Tang B, Zhang W, Ye C, Yuan M, Yang Z. Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study. Bioengineered 2021;12:8233-46. [PMID: 34592890 DOI: 10.1080/21655979.2021.1982273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Albhaisi SAM, Bajaj JS. The Influence of the Microbiome on NAFLD and NASH. Clin Liver Dis (Hoboken) 2021;17:15-8. [PMID: 33552480 DOI: 10.1002/cld.1010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sadiq FA. Is it time for microbiome-based therapies in viral infections? Virus Res 2021;291:198203. [PMID: 33132161 DOI: 10.1016/j.virusres.2020.198203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Chen LJ, He JT, Pan M, Liu JL, Zhang KK, Li JH, Wang LB, Xu LL, Chen YK, Zhang QY, Li DR, Xu JT, Xie XL. Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 Axis. Front Pharmacol 2021;12:716703. [PMID: 34381368 DOI: 10.3389/fphar.2021.716703] [Reference Citation Analysis]
14 Tang M, Li S, Wei L, Hou Z, Qu J, Li L. Do Engineered Nanomaterials Affect Immune Responses by Interacting With Gut Microbiota? Front Immunol 2021;12:684605. [PMID: 34594323 DOI: 10.3389/fimmu.2021.684605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Song W, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, Liu Y, Zhang HM, Guo W. Association of Gut Microbiota and Metabolites With Disease Progression in Children With Biliary Atresia. Front Immunol 2021;12:698900. [PMID: 34630385 DOI: 10.3389/fimmu.2021.698900] [Reference Citation Analysis]
16 Won SM, Park E, Jeong JJ, Ganesan R, Gupta H, Gebru YA, Sharma S, Kim DJ, Suk KT. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. Int J Mol Sci 2021;22:8309. [PMID: 34361075 DOI: 10.3390/ijms22158309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lucchetti M, Kaminska M, Oluwasegun AK, Mosig AS, Wilmes P. Emulating the gut-liver axis: Dissecting the microbiome's effect on drug metabolism using multiorgan-on-chip models. Curr Opin Endocr Metab Res 2021;18:94-101. [PMID: 34239997 DOI: 10.1016/j.coemr.2021.03.003] [Reference Citation Analysis]
18 Elaskandrany M, Patel R, Patel M, Miller G, Saxena D, Saxena A. Fungi, host immune response, and tumorigenesis. Am J Physiol Gastrointest Liver Physiol 2021;321:G213-22. [PMID: 34231392 DOI: 10.1152/ajpgi.00025.2021] [Reference Citation Analysis]
19 Liu X, Pan Y, Shen Y, Liu H, Zhao X, Li J, Ma N. Protective Effects of Abrus cantoniensis Hance on the Fatty Liver Hemorrhagic Syndrome in Laying Hens Based on Liver Metabolomics and Gut Microbiota. Front Vet Sci 2022;9:862006. [DOI: 10.3389/fvets.2022.862006] [Reference Citation Analysis]
20 Chen T, Li R, Chen P. Gut Microbiota and Chemical-Induced Acute Liver Injury. Front Physiol 2021;12:688780. [PMID: 34122150 DOI: 10.3389/fphys.2021.688780] [Reference Citation Analysis]
21 Liu F, Sun C, Chen Y, Du F, Yang Y, Wu G. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. J Clin Transl Hepatol 2021;9:917-30. [PMID: 34966655 DOI: 10.14218/JCTH.2021.00032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kirschner SK, Deutz NEP, Engelen MPKJ. Intestinal dysfunction in chronic disease. Curr Opin Clin Nutr Metab Care 2021;24:464-72. [PMID: 34138768 DOI: 10.1097/MCO.0000000000000780] [Reference Citation Analysis]
23 Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metab 2021;50:101143. [PMID: 33346069 DOI: 10.1016/j.molmet.2020.101143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03296-9] [Reference Citation Analysis]
25 Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, Azimirad M, Alavifard H, Mohsenifar Z, Davari M, Vaziri F, Moshiri A, Siadat SD, Zali MR. The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury. Microbiol Spectr 2021;9:e0048421. [PMID: 34549998 DOI: 10.1128/Spectrum.00484-21] [Reference Citation Analysis]